Literature DB >> 11834377

Caenorhabditis elegans as a host for the study of host-pathogen interactions.

Alejandro Aballay1, Frederick M Ausubel.   

Abstract

Recently, pathogenicity models that involve the killing of the genetically tractable nematode Caenorhabditis elegans by human pathogens have been developed. From the perspective of the pathogen, the advantage of these models is that thousands of mutagenized bacterial clones can be individually screened for avirulent mutants on separate petri plates seeded with C. elegans. The advantages of using C. elegans to study host responses to pathogen attack are the extensive genetic and genomic resources available and the relative ease of identifying C. elegans mutants that exhibit altered susceptibility to pathogen attack. The use of Caenorhabditis elegans as the host for a variety of human pathogens is discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11834377     DOI: 10.1016/s1369-5274(02)00293-x

Source DB:  PubMed          Journal:  Curr Opin Microbiol        ISSN: 1369-5274            Impact factor:   7.934


  62 in total

1.  Caenorhabditis elegans as a model to determine fitness of antibiotic-resistant Salmonella enterica serovar typhimurium.

Authors:  Wilhelm Paulander; Alexandra Pennhag; Dan I Andersson; Sophie Maisnier-Patin
Journal:  Antimicrob Agents Chemother       Date:  2006-11-20       Impact factor: 5.191

Review 2.  Worms and flies as genetically tractable animal models to study host-pathogen interactions.

Authors:  Eleftherios Mylonakis; Alejandro Aballay
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

3.  Cryptococcus neoformans gene involved in mammalian pathogenesis identified by a Caenorhabditis elegans progeny-based approach.

Authors:  Robin J Tang; Julia Breger; Alexander Idnurm; Kimberly J Gerik; Jennifer K Lodge; Joseph Heitman; Stephen B Calderwood; Eleftherios Mylonakis
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

4.  Using C. elegans for antimicrobial drug discovery.

Authors:  Athanasios Desalermos; Maged Muhammed; Justin Glavis-Bloom; Eleftherios Mylonakis
Journal:  Expert Opin Drug Discov       Date:  2011-06-01       Impact factor: 6.098

Review 5.  Evolution of host innate defence: insights from Caenorhabditis elegans and primitive invertebrates.

Authors:  Javier E Irazoqui; Jonathan M Urbach; Frederick M Ausubel
Journal:  Nat Rev Immunol       Date:  2010-01       Impact factor: 53.106

6.  Effects of methyl and inorganic mercury exposure on genome homeostasis and mitochondrial function in Caenorhabditis elegans.

Authors:  Lauren H Wyatt; Anthony L Luz; Xiou Cao; Laura L Maurer; Ashley M Blawas; Alejandro Aballay; William K Y Pan; Joel N Meyer
Journal:  DNA Repair (Amst)       Date:  2017-02-13

7.  Early colonization events in the mutualistic association between Steinernema carpocapsae nematodes and Xenorhabdus nematophila bacteria.

Authors:  Eric C Martens; Kurt Heungens; Heidi Goodrich-Blair
Journal:  J Bacteriol       Date:  2003-05       Impact factor: 3.490

8.  Virulence factors identified by Cryptococcus neoformans mutant screen differentially modulate lung immune responses and brain dissemination.

Authors:  Xiumiao He; Daniel M Lyons; Dena L Toffaletti; Fuyuan Wang; Yafeng Qiu; Michael J Davis; Daniel L Meister; Jeremy K Dayrit; Anthony Lee; John J Osterholzer; John R Perfect; Michal A Olszewski
Journal:  Am J Pathol       Date:  2012-07-28       Impact factor: 4.307

9.  C. elegans SWAN-1 Binds to EGL-9 and regulates HIF-1-mediated resistance to the bacterial pathogen Pseudomonas aeruginosa PAO1.

Authors:  Zhiyong Shao; Yi Zhang; Qi Ye; Jenifer Neeta Saldanha; Jo Anne Powell-Coffman
Journal:  PLoS Pathog       Date:  2010-08-26       Impact factor: 6.823

10.  Susceptibility of Caenorhabditis elegans to Burkholderia infection depends on prior diet and secreted bacterial attractants.

Authors:  Vaughn S Cooper; Wendy A Carlson; John J Lipuma
Journal:  PLoS One       Date:  2009-11-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.